why is retatrutide not fda approved Weight Loss Results:Trial Data and Status Retatrutide's TRIUMPH-1 result explains why

So how do we engage or revamp our primary care workforce to include more obesity training for primary care physicians to really manage this population? A drug by any other name Semaglutide , one of the top-selling drugs in the United States in 2024, is marketed as Wegovy for weight management, as Rybelsus in an oral formulation for managing Type 2 diabetes and as Ozempic for treating Type 2 diabetes, reducing cardiovascular risk in patients with Type 2 diabetes and reducing the risk of kidney disease worsening in adults with Type 2 diabetes and chronic kidney disease

The combination of Ozempic's gastrointestinal side effects with cannabis use could potentially exacerbate nausea or make it difficult to distinguish between medication side effects and cannabis-related symptoms

Many GLP-1 vision loss plaintiffs are diabetic patients

doi: 10.1007/s40279-014-0149-y

-